What's breaking now, across thousands of outlets.
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
We haven't written up this one. CNBC World has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
After a botched lethal injection in May, dozens of Tennessee medical professionals told the governor that healthcare professionals shouldn't help with executions, no matter the method.
FDA elevates salad dressing recall to highest risk level over Salmonella concerns as food safety remains under scrutiny.
Even relatively small increases in fine-particle air pollution can be followed by more asthma- and chronic obstructive pulmonary disease (COPD)-related emergency department visits, according to a…
A hospital in Japan has carried out the world's first surgery using sheets of commercially available heart muscle stem cells after the groundbreaking therapy was approved this year, one of the…
Severe pneumococcal disease requiring hospitalization, most commonly pneumonia, can be a sign of previously undiagnosed blood cancer and immunodeficiency in adult patients, according to a study from…
(MedPage Today) -- Mivocabtagene autoleucel (miv-cel), an autologous CD19 chimeric antigen receptor (CAR)-T cell therapy, showed benefits lasting 6 months or longer for generalized myasthenia gravis…
